Literature DB >> 1733959

Organization of the regulatory elements and nuclear activities participating in the transcription of the human apolipoprotein B gene.

D Kardassis1, V I Zannis, C Cladaras.   

Abstract

The human apolipoprotein B (apoB) promoter region (-150 to +124) is transcriptionally active in HepG2 and CaCo-2 but not in HeLa cells. In the present study, we demonstrate that transcription of the human apoB gene in hepatic cells is achieved through the interaction of proteins that bind to five regulatory elements, I (-118 to -98), II (-112 to -94), III (-86 to -62), IV (-72 to -53), and V (-53 to -33). Elements I, IV, and V can bind to bacterially expressed enhancer-binding protein (C/EBP) although with different affinities. In addition, elements I, IV, and V interact with at least two other heat-stable nuclear factors, designated NF-BA2 and NF-BA3, that are distinct from C/EBP. These activities have been separated by ion exchange chromatography and shown to produce footprints in elements I, IV, and V that are similar to those obtained with C/EBP. Element II is recognized by three activities designated NF-BCB1, NF-BCB2, and NF-BCB3, which have been separated by heparin-Sepharose chromatography. Saturation mutagenesis of the region established that they belong to a family of proteins recognizing the same motif, 5'-AAAAGCAAACAG-3'. Substitution mutations in element II that abolish binding of all three activities in vitro also reduce hepatic transcription in vivo to 10% of control, indicating that the binding of NF-BCB1, NF-BCB2, and NF-BCB3 activities is required for efficient transcription of the apoB gene. Furthermore, element III is recognized by the previously characterized nuclear factor NF-BA1, the binding of which is essential for the transcriptional activation of the apoB gene in hepatic and intestinal cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733959

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis.

Authors:  George Koutsodontis; Eleftheria Vasilaki; Wan-Chih Chou; Paraskevi Papakosta; Dimitris Kardassis
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

2.  Synergism between nuclear receptors bound to specific hormone response elements of the hepatic control region-1 and the proximal apolipoprotein C-II promoter mediate apolipoprotein C-II gene regulation by bile acids and retinoids.

Authors:  Dimitris Kardassis; Anastasia Roussou; Paraskevi Papakosta; Konstantinos Boulias; Iannis Talianidis; Vassilis I Zannis
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

3.  Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members.

Authors:  A Moustakas; D Kardassis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

4.  The mechanism by which the human apolipoprotein B gene reducer operates involves blocking of transcriptional activation by hepatocyte nuclear factor 3.

Authors:  B Paulweber; F Sandhofer; B Levy-Wilson
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

5.  Functional specificity of two hormone response elements present on the human apoA-II promoter that bind retinoid X receptor alpha/thyroid receptor beta heterodimers for retinoids and thyroids: synergistic interactions between thyroid receptor beta and upstream stimulatory factor 2a.

Authors:  Eudoxia Hatzivassiliou; George Koukos; Agnes Ribeiro; Vassilis Zannis; Dimitris Kardassis
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

6.  Quercetin represses apolipoprotein B expression by inhibiting the transcriptional activity of C/EBPβ.

Authors:  Makoto Shimizu; Juan Li; Jun Inoue; Ryuichiro Sato
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.